About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalGeneric Drug
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
355
By Phase
PHASE4: 2PHASE2/PHASE3: 1PHASE2: 1
By Status
ENROLLING_BY_INVITATION: 1RECRUITING: 1UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05655273Collaborator
Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients
PHASE4Enrolling by invitation
40 participants
Started: Jan 1, 2024 · Completed: Feb 28, 2026
NCT05089604Collaborator
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
PHASE4Recruiting
124 participants
Started: Jan 9, 2023 · Completed: Dec 31, 2026
NCT04879134Collaborator
Apomorphine Effects on Pain in Parkinson's Disease
PHASE2/PHASE3Unknown
40 participants
Started: Feb 28, 2022 · Completed: Jul 31, 2023
NCT01067443Collaborator
Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
PHASE2Completed
151 participants
Started: Mar 31, 2010 · Completed: Jun 30, 2011
Locations (1)
Headquarters
Saint-Laurent, QC, Canada
Map
Loading map...